Analysis reveals limited evidence on use of cannabis products in children with cancer

A recent analysis of all relevant published studies reveals a lack of evidence to determine the dosing, safety, and efficacy of medical marijuana or cannabis-containing products for managing symptoms experienced by children with cancer.

Risk Adjusted Net Present Value: What is the current valuation of SpringWorks Therapeutics’s BGB-3245

The revenue for BGB-3245 is expected to reach an annual total of $11 mn by 2034 globally based off GlobalData’s Expiry Model. The drug’s revenue

July 31, 2023

Doctors use problematic race-based algorithms to guide care every day. Why are they so hard to change?

This is Part 1 of Embedded Bias, a series revealing how race-based clinical algorithms pervade medicine and why it’s so difficult to change them. Pediatrician

September 3, 2024

Marinomed Biotech AG with important progress for Carragelose in 2024 – Biotech Investments

EQS-News: Marinomed Biotech AG / Key word(s): Study/Patent Marinomed Biotech AG with important progress for Carragelose in 2024 07.02.2024 / 07:45 CET/CEST The issuer is

February 8, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.